Estradiol Patches

Phase 2Small molecule

UUniversity of Colorado, Denver

Estradiol Patches is one of 2 small molecule programs targeting Infertility, Female. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Infertility, FemaleRecruiting

Infertility, FemalePhase 2

Recruiting

Competition

Competitive Landscape

2 competitors in Infertility, Female

#DrugCompanyPhaseTrials

Clomid

Ferring

Phase 3

2 2

Estradiol Patches

UUniversity of Colorado, Denver

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Phase 2Recruiting

Infertility, Female

NCT06686537

Clinical

Trials by Indication[1]

Treatment1 trial

A Treatment Study for Premenstrual Syndrome (PMS)

Completed·NNational Institute of Mental Health (NIMH)·Phase 1·NCT00001259·60 enrolled

Infertility, Female1 trial

Convergent Mechanisms Underlying Reprometabolic Syndrome in Women and Sheep

Recruiting·UUniversity of Colorado, Denver·Phase 2·NCT06686537·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Estradiol Patches. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Estradiol Patches compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Estradiol Patches. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Colorado, Denver company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: UUniversity of Colorado, Denver

Estradiol Patches

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Treatment1 trial

Infertility, Female1 trial

References

Drug Info

Quick Facts

Related News